Trial Profile
Peri-operative outcomes of eptifibatide bridging in patients undergoing thoracic surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- 26 Apr 2017 New trial record